1. Dakwar E, Levin FR. (2009). The Emerging Role of Meditation in Addressing Psychiatric Illness: A Review of the Literature, with a Focus on Substance Use Disorders. Harvard Review of Psychiatry. 17(4):254-67. PMCID: PMC3109319
2. Dakwar E, Nunes EV, Bisaga A, Carpenter KC, Mariani JJ, Sullivan MA, Raby W, Levin FR. (2011). A Comparison of Independent Depression and Substance-Induced Depression in Cannabis, Cocaine, and Opioid Dependent Treatment Seekers. American Journal on Addictions. Sep-Oct;20(5). 441-6. PMCID: PMC3600842
3. Dakwar E, Popii M, Coccaro EF. (2011). Lifetime history of cigarette use associated with aggression and impulsivity in both healthy and personality disordered volunteers. Journal of Personality Disorders, 25(5):645-655. PMCID: PMC3594993
4. Dakwar E, Mariani JJ, Levin FR. (2011) Mindfulness impairments among individuals seeking treatment for substance use disorders. American Journal of Drug and Alcohol Abuse, 37(3):165-9. PMCID: PMC3119030
5. Dakwar E, Blanco C, Warden D, Trivedi M, Nunes EV. (2012). Exercise and Mental Illness: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Journal of Clinical Psychiatry, 73(7):960-6. doi: 10.4088/JCP.11m07484. PMCID: PMC3652330
6. Dakwar E, Mahoney A, Pavlicova M, Glass A, Mariani J, Brooks D, Grabowski J, Levin FR. (2012) The Utility of ADHD Screening Instruments in Individuals with SUDs. Journal of Clinical Psychiatry, 73(11):e1372-8. doi: 10.4088/JCP.12m07895 PMCID: PMC3627386
7. Dakwar E, Levin FR, Foltin R, Nunes EV, Hart CL. (2014) The Effect of Sub-anesthetic Ketamine on Motivation to Quit and Cue-induced Craving in Cocaine Dependent Research
8. Dakwar E, Anerella C, Hart CL, Levin FR, Mathew SJ, Nunes EV. (2014) Therapeutic Infusions of Ketamine: Do the psychoactive effects matter? Drug and Alcohol Dependence. 14 Mar 1;136:153-7. doi: 10.1016/j.drugalcdep.2013.12.019
9. Dakwar E, Levin FR, Olfson M, Blanco C. (2014) Delays in Treatment Seeking for ADHD: Results from the NESARC. Psychiatric Services. Aug 1.
10. Dakwar E, Levin FR. (2014) Individual Mindfulness-based Psychotherapy for Cocaine or Cannabis Dependence: A Pilot Tolerability and Feasibility Trial. American Journal on Addictions. Nov-Dec;22(6):521-6
11. Dakwar E, Kleber HK. (2015) Naltrexone-facilitated Buprenorphine Discontinuation: A Feasibility Trial. J Substance Abuse Treatment. J Subst Abuse Treat. Jun;53:60-3.
12. Levin FR, Mariani JJ, Pavlicova M, Brooks D, Glass A, Mahony A, Nunes EV, Bisaga A, Dakwar E, Carpenter KM, Sullivan MA, Choi JC. (2016). Dronabinol and lofexidine for cannabis use disorder: A randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend. Feb 1;159:53-60.
13. Dakwar E, Nunes EV. (2016). New Directions in Medication-Facilitated Behavioral Treatment for Substance Use Disorders. Curr Psychiatry Rep. Jul;18(7):64
14. Dakwar E. (2016). The death and rebirth of hallucinogens. Drug and Alcohol Dependence. 165: 293-297. Impact Factor: 3.349 (2015) Contribution to publication: designed and executed study, assisted with data collection and analysis, and wrote manuscript A thought piece concerning the place of hallucinogens in treatment and research. published in one of the top addiction psychiatry journals.
15. Dakwar E, Hart CL, Levin FR, Nunes EV, Foltin RW. (2017) Cocaine self-administration disrupted by the N-methyl-D-aspartate receptor antagonist ketamine: a randomized, cross-over trial. Mol Psychiatry. Jan;22(1):76-81.
16. Dakwar E & Kleber HK. (2017) Minding the brain: the role of pharmacotherapy in substance use disorder treatment. Dialogues in Clinical Neuroscience. Sep; 19(3): 289-297. Impact Factor: 5.23 Contribution to publication: Wrote manuscript A review of the role of pharmacotherapy in substance use disorder treatment, published in one of the top neuroscience journals.
17. Sullivan M, Bisaga A, Pavlicova M, Choi CJ, Mishlen K, Carpenter KM, Levin FR, Dakwar E, Mariani JJ, Nunes EV. (2017). Long-Acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone Versus Buprenorphine. Am J Psychiatry. May 1;174(5):459-467.
18. Dakwar E, Hart CL, Nunes EV, Foltin RW, Hu MC, Levin FR. (2017) A sub-set of psychoactive effects may be critical to the behavioral impact of ketamine. Neuropharmacology. Nov;142:270-276.
19. Dakwar E; Nunes, EV, Hart, CL, et al. (2019) A single ketamine infusion improves treatment outcomes in cocaine dependent adults engaged in mindfulness-based behavioral modification: A randomized clinical trial. Am J Psych. Nov 1;176(11):923-930. doi: 10.1176/appi.ajp.2019.18101123. Impact Factor: 13.505 (2016) Contribution to publication: designed and executed study, assisted with data collection and analysis, and wrote manuscript
20. Dakwar E. (2019) Amphibious anti-depressants and other wonders. Am J Drug Alcohol Abuse. 45(2):115-116. doi: 10.1080/00952990.2019.1580288
21. Dakwar E, Levin FR, Hart CL, et al. (2020) A single ketamine infusion combined with motivational enhancement therapy for alcohol use disorder: A randomized midazolam-controlled trial. Am J Psych. Feb 1;177(2):125-133. doi: 10.1176/appi.ajp.2019.19070684. Impact Factor: 13.505 (2016) Contribution to publication: designed and executed study, assisted with data collection and analysis, and wrote manuscript
22. Dakwar E, Mahony A, Chou CJ, Pavlicova M, Brooks D, Mariani JP, Levin FR (2020). Guanfacine extended-release for cannabis use disorder: a pilot feasibility trial. Am J Drug Alcohol Abuse. 6(1):44-48. doi: 10.1080/00952990.2019.1620259
23. Rothberg RL, Azhari N, Haug NA, Dakwar E (2021). Mystical-type experiences occasioned by ketamine mediate its impact on at-risk drinking: Results from a randomized, controlled trial. J Psychopharm. Dec;35(2): 026988112097087. doi: 10.1177/0269881120970879.
24. Azhari N, Hu H, O’Malley KY, Blocker M, Dakwar E, Levin F, Dakwar E (2021). Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study. Am J Drug Alcohol Ab. Nov;47(1):1-6. doi: 10.1080/00952990.2020.1808982.
25. Franco Corso, S. J., O’Malley, K. Y., Subaiya, S., Mayall, D., & Dakwar, E. (2023). The role of nonordinary states of consciousness occasioned by mind-body practices in mental health illness. Journal of Affective Disorders, 335, 166-176. doi: 10.1016/j.jad.2023.04.116.
26. Marcus O., Dakwar E., (2023). Paradigm Lost. International Journal on Mental Health. In press. 1. “A case of hallucinogen intoxication” in “The Addiction Casebook.” Levounis and Herron (Eds), APA, 2014, pg 69-87.